UK markets closed

B.R.A.I.N. Biotechnology Research and Information Network AG (BNN.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
9.780.00 (0.00%)
At close: 10:06AM CEST
Full screen
Previous close9.78
Open9.78
Bid0.00 x 100000
Ask0.00 x 100000
Day's range9.78 - 9.78
52-week range6.72 - 11.10
Volume730
Avg. volume503
Market cap213.669M
Beta (5Y monthly)1.57
PE ratio (TTM)N/A
EPS (TTM)-0.33
Earnings date29 Aug 2019 - 02 Sept 2019
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est20.35
  • EQS Group

    BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives

    DGAP-News: BRAIN Biotech AG / Key word(s): Capital Increase15.09.2021 / 21:51 The issuer is solely responsible for the content of this announcement.Zwingenberg, September 15th, 2021BRAIN Biotech AG successfully placed new share capital for the financing of further growth initiatives- Around 10% new shares successfully placed- Approximately EUR 19 million proceeds for growth The Management Board of BRAIN Biotech AG has, with the approval of the Supervisory Board, successfully completed the issue

  • EQS Group

    BRAIN Biotech AG: BRAIN Biotech AG has successfully completed 10% cash capital increase from authorised capital with exclusion of statutory subscription rights

    BRAIN Biotech AG / Key word(s): Capital IncreaseBRAIN Biotech AG: BRAIN Biotech AG has successfully completed 10% cash capital increase from authorised capital with exclusion of statutory subscription rights15-Sep-2021 / 21:48 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Disclosure of inside information in accordance with

  • EQS Group

    BRAIN Biotech AG resolves on a cash capital increase from authorised capital

    DGAP-News: BRAIN Biotech AG / Key word(s): Capital Increase15.09.2021 / 17:45 The issuer is solely responsible for the content of this announcement.Zwingenberg, September 15th, 2021BRAIN Biotech AG resolves on a cash capital increase fromauthorised capitalThe Management Board of BRAIN Biotech AG today has resolved to increase the company's share capital against cash contribution. The company's share capital shall be increased against cash contribution by issuing new registered shares with no par